home :: clinical trials :: treatment trials :: clinical trials
CLINICAL TRIALS 

  AVAILABLE CLINICAL TRIALS
 
Melanoma Clinical Trials
  Ref # Title
Unresectable Locally Advance or Stage IV ECOG E2607 DASATINIB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR STAGE IV MUCOSAL, ACRAL AND VULVOVAGINAL MELANOMAS
Stage IIIc and IV VIRALYTICS VLA-007 A PHASE 2 STUDY OF THE EFFICACY AND SAFETY OF INTRATUMORAL CAVATAK(COXSACKIEVIRUS A21, CVA21) IN PATIENTS WITH STAGE IIIC AND STAGE IV MALIGNANT MELANOMA
Adjuvant Resected High Risk ECOG E1609 A PHASE III RANDOMIZED STUDY OF ADJUVANT IPILIMUMAB ANTI-CTLA4 THERAPY VERSUS HIGH-DOSE INTERFERON ALPHA-2B FOR RESECTED HIGH-RISK MELANOMA
Metastatic CTEP NCI 8443 RANDOMIZED PHASE II TRIAL OF TEMOZOLOMIDE VERSUS HYD-SULFATE AZD6244 IN PATIENTS WITH METASTATIC UVEAL MELANOMA
Metastatic DUS11T NILOTINIB IN TKI RESISTANT OR INTOLERANT PATIENTS WITH METASTATIC MUCOSAL, ACRAL, OR CHRONICALLY SUN DAMAGED MELANOMA
 



©2004 MSCCOP & Mount Sinai Medical Center